Sexual dysfunction. Sexual dysfunction, not caused by organic disorder or disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Natural menopause (neither surgical nor premature menopause); age 40-60, not having been more than 3 years since the onset of menopause; lack of acute heart diseases; lack of any serious mental illness; absence of severe psychological stress such as an accident or loss of a family member in the past 3 months; having sexual intercourse with husband; the absence of sexual dysfunction in husband; not using herbal medicines containing phytoestrogens or supplements of sexual hormones in any form; not having a drug abuser spouse; having the willingness to participate in interventions to improve sexual function Exclusion criteria: Being unwilling to cooperate in the ongoing investigation; having debilitating diseases (such as cancer) which prevent the person from participating in interventions; having a surgery during the intervention; having marital discord, divorce, death or illness of spouse during the intervention
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of sexual function. Timepoint: Before Intervention, 3 months after intervention. Method of measurement: Female Sexual Function Index (FSFI) questionnaire.;Life Quality. Timepoint: Before Intervention, 3 months after intervention. Method of measurement: WHO Quality of Life-BREF (WHOQOL-BREF) questionnaire.;Severity of menopausal symptoms. Timepoint: Before Intervention, 3 months after intervention. Method of measurement: Menopause Rating Scale (MRS) questionnaire.;Total Testosterone. Timepoint: Before Intervention, 3 months after intervention. Method of measurement: Enzyme immunoasay (EIA).;Dehydroepiandrosterone Sulfate (DHEAS). Timepoint: Before Intervention, 3 months after intervention. Method of measurement: Enzyme immunoasay (EIA).;SHBG. Timepoint: Before Intervention, 3 months after intervention. Method of measurement: Enzymo-immunometric assay (EIMA).;EStradiol. Timepoint: Before Intervention, 3 months after intervention. Method of measurement: Enzyme-Linked Fluorescent Immunoassay (FLFA). | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences, Midwifery and Nursing Department